OBJECTIVE: To determine the effect of the initial metabolic imbalance and its restoration after insulin therapy on adiponectin and acylated ghrelin levels in children with type 1 diabetes mellitus (T1DM). STUDY DESIGN: Twenty prepubertal children with newly diagnosed T1DM were prospectively studied at diagnosis and after 1 and 4 months of therapy. Body mass index (BMI) and serum levels of adiponectin, resistin, total and acylated ghrelin, leptin, tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6) were determined. The control group comprised 40 healthy prepubertal children. RESULTS: BMI was decreased at diagnosis, normalized at 1 month, and remained so thereafter. Adiponectin levels at diagnosis were similar to controls, increasing significantly after 1 month and normalizing at 4 months. Acylated ghrelin levels were lower at diagnosis, with a significant increase at 1 month and normalizing at 4 months. Resistin levels were normal at all time points. Leptin levels were decreased, while TNF-alpha and IL-6 were increased at diagnosis and normalized at 1 month. CONCLUSIONS: These findings suggest that BMI is not the main predictor of acylated ghrelin or adiponectin levels in newly diagnosed T1DM subjects and that these peptides may play an important role in the metabolic adaptation in this disease.
OBJECTIVE: To determine the effect of the initial metabolic imbalance and its restoration after insulin therapy on adiponectin and acylated ghrelin levels in children with type 1 diabetes mellitus (T1DM). STUDY DESIGN: Twenty prepubertal children with newly diagnosed T1DM were prospectively studied at diagnosis and after 1 and 4 months of therapy. Body mass index (BMI) and serum levels of adiponectin, resistin, total and acylated ghrelin, leptin, tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6) were determined. The control group comprised 40 healthy prepubertal children. RESULTS: BMI was decreased at diagnosis, normalized at 1 month, and remained so thereafter. Adiponectin levels at diagnosis were similar to controls, increasing significantly after 1 month and normalizing at 4 months. Acylated ghrelin levels were lower at diagnosis, with a significant increase at 1 month and normalizing at 4 months. Resistin levels were normal at all time points. Leptin levels were decreased, while TNF-alpha and IL-6 were increased at diagnosis and normalized at 1 month. CONCLUSIONS: These findings suggest that BMI is not the main predictor of acylated ghrelin or adiponectin levels in newly diagnosed T1DM subjects and that these peptides may play an important role in the metabolic adaptation in this disease.
Authors: K Karavanaki; E Tsoka; M Liacopoulou; C Karayianni; V Petrou; E Pippidou; M Brisimitzi; M Mavrikiou; K Kakleas; C Dacou-Voutetakis Journal: J Endocrinol Invest Date: 2008-05 Impact factor: 4.256
Authors: Charles A Steiner; Andrej Janez; Mojca Jensterle; Katrin Reisinger; Thomas Forst; Andreas Pfützner Journal: J Diabetes Sci Technol Date: 2007-03
Authors: Jesus A Gutierrez; Patricia J Solenberg; Douglas R Perkins; Jill A Willency; Michael D Knierman; Zhaoyan Jin; Derrick R Witcher; Shuang Luo; Jude E Onyia; John E Hale Journal: Proc Natl Acad Sci U S A Date: 2008-04-28 Impact factor: 11.205
Authors: David M Maahs; Richard F Hamman; Ralph D'Agostino; Lawrence M Dolan; Guiseppina Imperatore; Jean M Lawrence; Santica M Marcovina; Elizabeth J Mayer-Davis; Catherine Pihoker; Dana Dabelea Journal: J Pediatr Date: 2009-07 Impact factor: 4.406
Authors: Rachel G Miller; Stuart J McGurnaghan; Suna Onengut-Gumuscu; Wei-Min Chen; Helen M Colhoun; Stephen S Rich; Trevor J Orchard; Tina Costacou Journal: J Diabetes Complications Date: 2021-01-09 Impact factor: 2.852
Authors: Behiye Özcan; Patric J D Delhanty; Martin Huisman; Jenny A Visser; Sebastian J Neggers; Aart Jan van der Lely Journal: Diabetol Metab Syndr Date: 2021-07-22 Impact factor: 3.320